Regenxbio (RGNX) Stock News
$RGNX · NASDAQ · 4 stories in 30 daysBORSA has published 4 stories on Regenxbio (RGNX) in the past 30 days. BORSA’s news read on RGNX is bullish at 61/100, unchanged over 24 hours, based on 1 company event over the past 7 days. RGNX last closed at $8.07 on Oct 9, up 8.61% over five sessions and down 5.72% over the past month. Regenxbio’s next earnings report is scheduled for Thursday, Nov 5.
The wire on $RGNX
newest first · updated · direct subject stories onlyREGENXBIO to Host Investor Event on Sura-vec in Wet AMD on October 20
REGENXBIO (RGNX) will hold an investor event on October 20, 2026, at 1:00 PM ET in New York and via webcast. The event will cover the sura-vec clinical program, including the ATMOSPHERE and ASCENT pivotal trials, with perspectives from retina specialists. Topline pivotal data is anticipated in Q4 2026.
neutral 50 · impact 40